Call Matthew
Insider CIK 1816207 · ITOS Chief Operating Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ITOS iTeos Therapeutics, Inc. | D To issuer deriv | 2025-08-29 | 2025-08-29 | 9,063 | — | $0 | 0 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | D To issuer deriv | 2025-08-29 | 2025-08-29 | 135,937 | — | $0 | 0 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | D To issuer deriv | 2025-08-29 | 2025-08-29 | 66,170 | — | $0 | 0 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | D To issuer deriv | 2025-08-29 | 2025-08-29 | 41,694 | — | $0 | 0 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | D To issuer deriv | 2025-08-29 | 2025-08-29 | 17,074 | — | $0 | 0 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | D To issuer deriv | 2025-08-29 | 2025-08-29 | 146,835 | — | $0 | 0 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | U Tender | 2025-08-29 | 2025-08-29 | 161,898 | — | $0 | 0 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | A Award deriv | 2025-03-07 | 2025-03-11 | 145,000 | — | $0 | 145,000 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | A Award | 2025-03-07 | 2025-03-11 | 24,000 | — | $0 | 161,898 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | A Award deriv | 2024-03-07 | 2024-03-08 | 225,000 | — | $0 | 225,000 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | A Award | 2023-12-05 | 2023-12-07 | 44,000 | — | $0 | 137,898 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | M Exercise deriv | 2023-03-28 | 2023-03-29 | 40,226 | — | $0 | 107,864 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | M Exercise | 2023-03-28 | 2023-03-29 | 40,226 | $2.95 | $118.7K | 93,898 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | A Award deriv | 2023-03-09 | 2023-03-10 | 130,000 | — | $0 | 130,000 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | A Award deriv | 2022-03-11 | 2022-03-14 | 85,000 | — | $0 | 85,000 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | M Exercise deriv | 2021-07-30 | 2021-08-05 | 53,672 | — | $0 | 148,090 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | M Exercise | 2021-07-30 | 2021-08-05 | 53,672 | $2.95 | $158.3K | 53,672 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | A Award deriv | 2021-06-24 | 2021-06-25 | 72,000 | — | $0 | 72,000 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | A Award deriv | 2021-03-01 | 2021-03-03 | 72,000 | — | $0 | 72,000 | SEC↗ |